"Can Extinction Be Prevented?" Australia Embarks on First Vaccination Campaign to Protect Rare Wild Birds from H5N1

Australia Enters a New Phase with "Vaccines for Wildlife"

After years of vigilance against the entry of highly pathogenic avian influenza H5N1, Australia has finally entered a new phase of its biosecurity policy.

 

The Australian government has announced plans to begin vaccinating native birds that are particularly vulnerable to H5N1.

In the initial phase, approximately AUD 2 million worth of vaccines, around 1,500 vials, have been prepared.

The initial targets are birds under human care in zoos and breeding facilities, where infection could severely impact the survival of the species.

This is not merely a "bird disease control" measure.

For Australia, with its unique ecosystems, the use of vaccines signifies a "preventive measure against extinction" to avoid losing endemic species to infectious diseases.

Agriculture Minister Julie Collins acknowledges that it is impossible to completely stop the spread of H5 avian influenza among wild birds.

Thus, the policy goal is shifting from "eliminating the virus from Australia" to "protecting irreplaceable species, assuming the spread of infection."

 

A Dramatic Change in Just Weeks Since First Confirmation in June

H5N1 was officially confirmed on the Australian mainland for the first time in June 2026.

Although infections had been confirmed on Heard Island, a sub-Antarctic Australian territory, the mainland had long been considered the "last continent" left behind by the global spread of H5N1.

That situation has dramatically changed.

Initially detected in migratory seabirds, the infection spread to native Australian birds, with mass deaths subsequently confirmed.

As of August 10, the Australian government reported 231 confirmed cases of wild birds testing positive.

By state, South Australia had the most with 163 cases, followed by Victoria with 53, Western Australia with 10, New South Wales with 4, and Queensland with 1.

While the numbers suggest only a few hundred birds, the reason experts are alarmed is not just the "number of confirmed cases."

The infection status of wildlife is heavily influenced by the number of individuals that can be tested.

It's impossible to test all birds living along coastlines, wetlands, uninhabited islands, and vast inland areas.

The confirmed infections may only represent a portion of the actual spread.

More importantly, the virus has started to spread from migratory birds to native birds.

Once the virus is maintained within local wild bird populations, it becomes extremely difficult for humans to completely sever the transmission routes.

Why Are Australian Birds Particularly Important?

Australia is home to about 850 bird species, approximately 45% of which are endemic and do not naturally occur elsewhere in the world.

This means that mass deaths due to H5N1 could lead not just to a reduction in numbers but to the extinction of the species from the planet.

Particularly concerning are endangered species with already low population numbers.

Species like the Orange-bellied Parrot and Regent Honeyeater are difficult to rely solely on wild populations for future survival, and are managed through captive breeding and conservation facilities.

The rare black cockatoos of Western Australia are also of high conservation importance.

If such birds become infected with H5N1 in captivity, decades of breeding efforts could suffer a significant setback in a short period.

Conversely, birds that humans can identify and regularly check for health are easier to vaccinate than wild birds.

Therefore, the government will first begin vaccinations with important populations under human care.

The strategy is not to save all wild birds but to prioritize "birds whose population loss would make species recovery difficult."

Vaccines Are Not a Panacea

The most important point in this announcement is that "securing vaccines does not solve the problem."

Currently available avian influenza vaccines were primarily developed with poultry in mind.

However, Australia's native birds are highly diverse in size and physiology.

The same method may not work for small parrots, large black cockatoos, and seabirds.

In preparation for actual deployment, Australia has conducted safety and efficacy trials on multiple species over approximately 18 months.

Another major issue is the "two-dose requirement."

In some cases, additional doses are needed to achieve sufficient efficacy, which is feasible for captive birds but extremely challenging for wild birds.

Even capturing a wild bird once requires specialized staff, permits, and equipment.

Finding and capturing the same bird again for a booster shot weeks later raises the difficulty significantly.

Environment Minister Murray Watt has indicated that while vaccinations for wild birds will be carried out where possible, capturing the same individual twice is challenging.

Thus, vaccines are most practically effective for rare species that can be managed, isolated populations on islands, and birds managed in breeding facilities.

"Preserving Species" Rather Than "Protecting All Individuals"

When it comes to wildlife disease control, one might think, "Just vaccinate as many animals as possible."

However, with the current H5N1 situation, the approach is slightly different.

Capturing and vaccinating millions of wild birds is not realistic.

Therefore, the important concept is to protect "populations" rather than individuals.

For example, if an endangered species has only a few hundred individuals left worldwide,

protecting a few dozen or a few hundred key breeding individuals from infection could leave the possibility of rebuilding the population, even if large-scale deaths occur in the wild.

In New Zealand, a similar approach is already being taken, with vaccinations for conservation populations, including rare birds like the Kakapo and Takahe.

Australia's current policy is more akin to "insurance to preserve genetically and conservationally important populations" rather than mass vaccination of a broad range of wild birds.

It's Not Just a Bird Problem

Although it's called "avian influenza," the globally spreading H5N1 is not a virus that only affects birds.

Infections in various mammals, including marine mammals, have been reported overseas.

In Australia, there is particular concern for marine mammals like sea lions and seals, which share habitats with seabirds.

Additionally, predators and scavengers that eat dead birds may have opportunities for infection.

Marsupials like the Tasmanian Devil and Quoll, iconic to Australia, may come into contact with the virus by consuming bird carcasses, raising concerns among experts.

This highlights the ecological risk of H5N1.

The death of large numbers of seabirds would not only affect birds.

It could have cascading effects on animals that lose their food source, those that consume large numbers of carcasses, and island ecosystems formed by bird nesting, among other levels.

It is an infectious disease and a biodiversity issue simultaneously.

The Risk to Humans Is Currently "Low"

The name H5N1 may cause some to worry about a new human pandemic.

However, Australian authorities currently assess the health risk to humans as low.

As of August 10, the current H5 avian influenza has not been detected in Australia's poultry industry or other agricultural production systems.

This is an important point.

The spread of infection among wild birds is not the same as spreading among humans.

However, close contact with infected birds or carcasses should be avoided.

If multiple sick or dead birds are found, it is recommended to avoid direct contact, record the location and situation, and report it to authorities.

For pets, it is important to keep dogs away from dead birds and cats away from wild birds.

On Social Media, "Finally Started" and "Too Late" Intersect

The introduction of the vaccine has just been announced, and there aren't enough social media posts about the announcement itself yet.

However, looking at the social media discussions about Australia's H5N1 measures until just before the announcement, public opinion is largely divided into two.

One is the criticism that "vaccination should have been advanced sooner."

In Reddit's Australia-related communities, while New Zealand's vaccination of rare species is praised, there are notable concerns about whether Australia's response is slow.

Strong anxieties are also expressed, such as "We knew it was coming, but the measures are insufficient" and "Imagining a future without wild birds is sad."

In regions already affected by large-scale wildfires and habitat loss from 2019 to 2020, there is particularly strong fear of H5N1 becoming a new pressure.

On the other hand, some users argue that "it's not accurate to say Australia has done nothing."

The government had established a monitoring network, conducted vaccine trials, risk assessments, and invested in systems to analyze bird movements even before H5N1 reached the mainland.

In New Zealand, not all wild birds are vaccinated; the focus is on extremely rare birds that can be individually identified and tracked.

This point is highlighted, with opinions stating that "it's difficult to make a simple comparison between the two countries."

With Australia now moving towards actual vaccine deployment, one question repeatedly asked on social media—"When will the transition from preparation to execution happen?"—has been answered.

Excessive Fear and Misinformation on Social Media

When the topic is infectious diseases and vaccines, not only scientifically grounded information spreads on social media.

Regarding H5N1, there are posts suggesting a human pandemic is already certain and claims linking vaccine policies to conspiracies.

In Australia, shortly after H5N1 was confirmed on the mainland, political statements linking the emergence of avian influenza with vaccine sales by pharmaceutical companies sparked debate.

In such an information environment, it's crucial to separate the three points: "infection is spreading among wild birds," "the current risk to humans is low," and "wildlife vaccines are introduced for different policy purposes than human vaccines."

The primary goal of this vaccination program is not pandemic prevention for humans.

It is to prevent Australia's unique wildlife from falling into an irrecoverable state due to mass deaths.

Why New Zealand Is a Comparison Target

New Zealand frequently appears as a comparison target in Australian social media and reports.

New Zealand confirmed domestic H5N1 infections in July 2026.

However, even before that, it had been advancing vaccine trials for rare birds and had already begun vaccinations for conservation-important birds when infections were confirmed.

Particularly for birds like the Kakapo and Takahe, which have small populations and are tracked individually for location and health, the vaccine strategy aligns well.

However, the same method cannot be used in Australia's coasts and wetlands, where hundreds of thousands of birds move freely.

The Australian government's initial focus on birds in captivity takes into account such practical constraints.

While New Zealand's experience is an important reference, it is not a simple model of "vaccinate and protect all wild birds nationwide."

"Wildlife Resilience" More Important Than Vaccines

Conservation groups emphasize not relying solely on vaccines.

When birds face infectious diseases, the damage they suffer varies depending on whether the population is already weakened.

Populations under multiple stresses, such as habitat loss, invasive predators, environmental pollution, climate change, and food shortages, have less capacity to recover when a new infectious disease is added.

Therefore, H5N1 measures must include habitat conservation, invasive species control, breeding site management, and wildlife population monitoring.

Environmental and conservation groups in Australia are calling for a AUD 200 million "wildlife resilience" investment as a response to H5N1.

This approach focuses not just on chasing the virus but on bringing wildlife closer to a state where they can withstand infectious diseases.

Vaccines are just one part of this.

Three Key Issues to Focus on Moving Forward

The biggest focus moving forward is first, "which species to prioritize."

There is a limited supply of vaccines and a limited number of specialized staff who can capture and vaccinate.

Decisions must be made by combining factors such as mortality rate upon infection, population size, reproductive capacity, distribution range, and extinction risk.

The second issue is how far vaccination can be extended to wild individuals.

There is potential in easily trackable locations like islands and small breeding sites, but continent-wide vaccination is not realistic.##HTML_TAG_